Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer
Purpose: High-risk Endometrial Cancer (EC) treatment decisions have been informed by two large, randomized trials: GOG-258 and PORTEC-3. Directly comparing these studies to determine the optimal treatment strategy remains challenging as neither included all three arms of interest: chemotherapy alone...
Saved in:
| Main Authors: | Megan E Lander, John Vargo, Runjia Li, G.K. Balasubramani, Ron Buckanovich, Jamie Lesnock, Alison Garrett, Shannon Rush, Paniti Sukumvanich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Gynecologic Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578925000815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ADJUVANT TREATMENT OF GASTRIC CANCER
by: D. T. Arybzhanov, et al.
Published: (2017-02-01) -
Impact of adjuvant chemotherapy on relapse-free survival of patients with locally advanced cervical cancer
by: M. P. Smirnova, et al.
Published: (2022-01-01) -
Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17–18 October 2024
by: Deepti Ravi, et al.
Published: (2025-07-01) -
Major and minor perineural invasion in salivary gland cancer
by: Fei Liu, et al.
Published: (2025-01-01) -
Toxicity profile of double-agent adjuvant chemotherapy after concurrent chemoradiation and brachytherapy in locally advanced cervical cancer: Comparison with standard chemoradiation protocol
by: Tejas Pandya, et al.
Published: (2019-01-01)